(Q57953657)

1

0 references

JH Rodman

2

0 references

BL Robbins

3

0 references

A Fridland

4

0 references

J Gandía

5

0 references

J Hitti

6

0 references

A Bardeguez

7

0 references

MH Rathore

8

0 references

A Gonzalez Garcia

9

0 references

M Cababasay

10

0 references

P Samson

11

0 references

YJ Bryson

13

0 references

A Dorenbaum

Management of human immunodeficiency virus infection in pregnancy

14

0 references

publication date

October 2007

0 references

published in

HIV Medicine

0 references

volume

8

0 references

issue

7

0 references

page(s)

451-456

0 references

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00495.X

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00495.X

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00495.X

Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00495.X

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00495.X

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study G

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00495.X

The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00495.X

Nevirapine: pharmacokinetic considerations in children and pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00495.X

Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00495.X

Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00495.X